We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+3.95%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$11.9B
AUM Growth
+$1.51B
Cap. Flow
+$1.35B
Cap. Flow %
11.39%
Top 10 Hldgs %
18.01%
Holding
1,342
New
336
Increased
335
Reduced
279
Closed
379

Top Buys

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$185M
2
SPGI icon
S&P Global
SPGI
+$152M
3
CHTR icon
Charter Communications
CHTR
+$137M
4
PYPL icon
PayPal
PYPL
+$89.8M
5
TMUS icon
T-Mobile US
TMUS
+$88.9M

Top Sells

Rank Stock Value
1
BKNG icon
Booking.com
BKNG
+$96.4M
2
ADBE icon
Adobe
ADBE
+$87.6M
3
MSFT icon
Microsoft
MSFT
+$81.4M
4
HUM icon
Humana
HUM
+$79.3M
5
CMCSA icon
Comcast
CMCSA
+$77.9M

Sector Composition

Rank Sector Weight
1 Healthcare 18.99%
2 Consumer Discretionary 12.86%
3 Communication Services 12.29%
4 Financials 10.52%
5 Technology 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOM icon
1201
ExxonMobil
XOM
$651B
-39,714
Closed -$3.32M
YRD
1202
Yiren Digital
YRD
$103M
-74,201
Closed -$864K
ZION icon
1203
Zions Bancorporation
ZION
$10.1B
-61,566
Closed -$1.49M
JBTM
1204
JBT Marel
JBTM
$7.14B
-12,313
Closed -$695K
BIG
1205
DELISTED
Big Lots, Inc.
BIG
-25,771
Closed -$1.17M
CONN
1206
DELISTED
Conn's Inc.
CONN
-11,356
Closed -$141K
SLCA
1207
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
-88,456
Closed -$2.01M
TARO
1208
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
-5,787
Closed -$829K
ERF
1209
DELISTED
Enerplus Corporation
ERF
-162,543
Closed -$639K
DOOR
1210
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
-8,597
Closed -$563K
TRVN
1211
DELISTED
Trevena, Inc.
TRVN
-354
Closed -$1.83M
SPLK
1212
DELISTED
Splunk Inc
SPLK
-5,167
Closed -$253K
DMK
1213
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
-5,560
Closed -$2.39M
HT
1214
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
-9,923
Closed -$212K
INFI
1215
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
-49,589
Closed -$261K
KDNY
1216
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
-22,332
Closed -$1.43M
CAJ
1217
DELISTED
Canon, Inc.
CAJ
-19,090
Closed -$569K
STOR
1218
DELISTED
STORE Capital Corporation
STOR
-96,300
Closed -$2.49M
IVC
1219
DELISTED
Invacare Corporation
IVC
-13,510
Closed -$178K
BNFT
1220
DELISTED
Benefitfocus, Inc.
BNFT
-8,592
Closed -$287K
OTIC
1221
DELISTED
Otonomy, Inc.
OTIC
-280,927
Closed -$4.19M
CLR
1222
DELISTED
CONTINENTAL RESOURCES INC.
CLR
-132,831
Closed -$4.03M
SHLX
1223
DELISTED
Shell Midstream Partners, L.P.
SHLX
-101,036
Closed -$3.7M
DRE
1224
DELISTED
Duke Realty Corp.
DRE
-37,474
Closed -$845K
SNP
1225
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
-20,697
Closed -$1.35M

Similar funds

Marshall Wace's Q2 2016 Portfolio in Review

As of Q2 2016, Marshall Wace held 1,342 positions worth $11.9B, up 15% from $10.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Marshall Wace deployed $1.35B of net new capital in Q2 2016, opening 336 new positions and adding to 335 existing holdings. Its largest new stake was S&P Global: 1,415,750 shares worth $152M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Booking.com, an estimated $96.4M trimmed.

  • Marshall Wace's largest Q2 2016 buy was S&P Global: 1,415,750 shares worth $152M.
  • Marshall Wace added most to Shire pic in Q2 2016, an estimated $185M increase.
  • Marshall Wace's biggest Q2 2016 reduction was Booking.com, cutting an estimated $96.4M.
  • Marshall Wace fully exited CABLEVISION SYS CP NY GRP CL-A in Q2 2016, selling an estimated $64.7M.
  • Marshall Wace's ten largest holdings make up 18% of its $11.9B portfolio in Q2 2016.
  • Marshall Wace opened 336 new positions and closed 379 in Q2 2016.
  • Marshall Wace's portfolio value rose 15% quarter-over-quarter to $11.9B.

Based on Marshall Wace's 13F filing for Q2 2016, filed 12 Aug 2016.